Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 94066

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 20, 2024
Product types
Drug
Classifications
Class III
Statuses
Ongoing
Recalling firm wording
Contract Pharmaceuticals Limited Canada

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

D-0364-2024
Recall number
D-0364-2024
Initiated
February 20, 2024
Classification
Class III
Status
Ongoing
Quantity
45,875 bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Out of specification

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Code information

Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/2025

Distribution pattern

Nationwide in the U.S. and Puerto Rico

drug · product 2 of 2

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

D-0365-2024
Recall number
D-0365-2024
Initiated
February 20, 2024
Classification
Class III
Status
Ongoing
Quantity
11,750 bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Out of specification

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Code information

Lot #: 119874; Exp 06/30/2025

Distribution pattern

Nationwide in the U.S. and Puerto Rico